Prateek Kumar Panda

Dr. Prateek Kumar Panda

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2023 in Epilepsia Open
Verified
Journal Article
Open access
BNBalamurugan Nagarajan
Balamurugan Nagarajan
VGVykuntaraju K. Gowda
Vykuntaraju K. Gowda
SYSangeetha Yoganathan
Sangeetha Yoganathan
ISIndar Kumar Sharawat
Indar Kumar Sharawat
KSKavita Srivastava
Kavita Srivastava
JSJitendra Kumar Sahu
Jitendra Kumar Sahu
Objective: Literature on the genotypic spectrum of Infantile Epileptic Spasms Syndrome (IESS) in children is scarce in developing countries. This multicentre collaboration evaluated the genotypic and phenotypic landscape of genetic IESS in Indian children.Methods: Between January 2021 and June 2022, this cross‐sectional study was conducted at six centers in India. Children with genetically confirmed IESS, without definite structural‐genetic and structural‐metabolic etiology, were recruited and underwent detailed in‐person assessment for phenotypic characterization. The multicentric data on the genotypic and phenotypic characteristics of genetic IESS were collated and analyzed.Results: Of 124 probands (60% boys, history of consanguinity in 15%) with genetic IESS, 105 had single gene disorders (104 nuclear and one mitochondrial), including one with concurrent triple repeat disorder (fragile X syndrome), and 19 had chromosomal disorders. Of 105 single gene disorders, 51 individual genes (92 variants including 25 novel) were identified. Nearly 85% of children with monogenic nuclear disorders had autosomal inheritance (dominant‐55.2%, recessive‐14.2%), while the rest had X‐linked inheritance. Underlying chromosomal disorders included trisomy 21 (n = 14), Xq28 duplication (n = 2), and others (n = 3). Trisomy 21 (n = 14), ALDH7A1 (n = 10), SCN2A (n = 7), CDKL5 (n = 6), ALG13 (n = 5), KCNQ2 (n = 4), STXBP1 (n = 4), SCN1A (n = 4), NTRK2 (n = 4), and WWOX (n = 4) were the dominant single gene causes of genetic IESS. The median age at the onset of epileptic spasms (ES) and establishment of genetic diagnosis was 5 and 12 months, respectively. Pre‐existing developmental delay (94.3%), early age at onset of ES (<6 months; 86.2%), central hypotonia (81.4%), facial dysmorphism (70.1%), microcephaly (77.4%), movement disorders (45.9%) and autistic features (42.7%) were remarkable clinical findings. Seizures other than epileptic spasms were observed in 83 children (66.9%). Pre‐existing epilepsy syndrome was identified in 21 (16.9%). Nearly 60% had an initial response to hormonal therapy.Significance: Our study highlights a heterogenous genetic landscape and phenotypic pleiotropy in children with genetic IESS.

10 November 2020 in Journal of Child Neurology
Verified
Journal Article
Closed access
PDF file
ISIndar Kumar Sharawat
Indar Kumar Sharawat
PPPrateek Kumar Panda
Prateek Kumar Panda
Background: The ongoing COVID-19 pandemic and the lockdown measures have forced clinicians across the world to look on telemedicine. Although migraine as such seems an ideal option for telemedicine, a systematic study reviewing feasibility, efficacy, and advantages of current advanced telecommunication technologies in children with migraine is lacking. Methods: Clinical details of telephonic consultations performed between March 25 and June 4, 2020, including migraine characteristics, analgesic/prophylactic drug regimens, headache frequency/severity/disability, compliance, drug-related/unrelated adverse effects and unavailability of drugs were recorded. Suitable change in the dose/commercial brand of drug regimen and the addition of new drugs were done as required. Voice call, text messages, picture/video messages, and all other possible measures were used to accumulate maximum clinical information in real time. Unless contacted for trivial reasons, most children were later followed up telephonically to ensure health care concern was resolved and to fill up one 6-item trichotomous quality control questionnaire. Results: A total of 146 telephone consultations were performed in 51 participants. Thirty-six patients were identified to have 42 significant clinical events (worsening clinical status/partial response to medications [18; 44%], drug-related adverse effects [10; 19%], unrelated systemic complaints [7; 13%], and worsening of headache due to stress/triggers [7; 13%]). In the rest of the patients, the query of the caregiver included concern regarding COVID-19–related symptoms. Twenty-nine children required increment in drug dose or addition of new drug or commercial brand. Around 90% of caregivers were satisfied with the quality of teleconsultation. Conclusion: Teleconsultation is a feasible and efficacious option, with excellent caregiver satisfaction for children with migraine.

1 February 2021 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
ISIndar Kumar Sharawat
Indar Kumar Sharawat
PPPrateek Kumar Panda
Prateek Kumar Panda
AKAnanthanarayanan Kasinathan
Ananthanarayanan Kasinathan
PPPragnya Panda
Pragnya Panda
LDLesa Dawman
Lesa Dawman
KJKriti Joshi
Kriti Joshi

17 May 2021 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
PPPrateek Kumar Panda
Prateek Kumar Panda
PPPragnya Panda
Pragnya Panda
LDLesa Dawman
Lesa Dawman
ISIndar Kumar Sharawat
Indar Kumar Sharawat

19 April 2021 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
ISIndar Kumar Sharawat
Indar Kumar Sharawat
PPPrateek Kumar Panda
Prateek Kumar Panda
RSRakesh Kumar Sihag
Rakesh Kumar Sihag
PPPragnya Panda
Pragnya Panda
LDLesa Dawman
Lesa Dawman

1 October 2021 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
ISIndar Kumar Sharawat
Indar Kumar Sharawat
PPPrateek Kumar Panda
Prateek Kumar Panda
PPPragnya Panda
Pragnya Panda
LDLesa Dawman
Lesa Dawman